Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: Activity of the isolated enzyme on low-density lipoproteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 2, 1997, Pages 300-309

  Hurt Camejo, Eva ^a   Andersen, Sonja ^b   Standal, Rune ^b   Rosengren, Birgitta ^a   Sartipy, Peter ^a   Stadberg, Elizabeth ^c   Johansen, Berit ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

atherosclerosis; inflammation; macrophages; vascular smooth muscle cells

Indexed keywords

LIPOSOME; LOW DENSITY LIPOPROTEIN; LY 311727; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2; SECRETORY NONPANCREATIC PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0031029342     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.2.300     Document Type: Article

References (3)

1. 2. J Biol Chem. 1994;269:13057-13060.
2. Marcus AJ, Hajjar DP. Vascular transcellular signaling. J Lipid Res. 1993:34:2017-2031.
3. Evangelou AM. Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. Prostaglandins Leukot Essent Fatty Acids. 1994;50:1-28.